Director/PDMR Shareholding

RNS Number : 8929Y

Hikma Pharmaceuticals Plc

17 May 2021

 

Hikma Pharmaceuticals PLC - EIP B and EIP C Vesting

LONDON, 17 May 2021: Hikma Pharmaceuticals PLC (LSE: HIK) (NasdaqDubai: HIK) ("Hikma") (LEI: 549300BNS685UXH4JI75) announces that the following Persons Discharging Managerial Responsibility ("PDMR") have received shares as a result of the vesting of their conditional share awards which were granted on 17 May 2019 under the 2014 Executive Incentive Plan ("EIP") Element B and granted on 16 May 2018 under the 2014 EIP Element C.  The Element B awards vested two years after grant and the Element C awards vested three years after grant.

Notification and public disclosure of transactions by persons discharging managerial responsibilities

Mazen Darwazah

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Mazen Darwazah
2	Reason for the notification
a)	Position/status	Executive Vice Chairman
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Hikma Pharmaceuticals PLC
b)	LEI	549300BNS685UXH4JI75
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083
b)	Nature of the transaction	Shares acquired from the vesting of conditional awards on 16 May 2021 under the EIP Element C.  All Shares were retained.
c)	Price(s) and volume(s)	Price(s): £nil Volume(s): 12,042
d)	Aggregated information -  Volume   -  Price Total	12,042 £0.00 £0.00
e)	Date of the transaction	17 May 2021
f)	Place of the transaction	London Stock Exchange (XLON)

Riad Mishlawi

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Riad Mishlawi
2	Reason for the notification
a)	Position/status	PDMR
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Hikma Pharmaceuticals PLC
b)	LEI	549300BNS685UXH4JI75
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083
b)	Nature of the transaction	Shares acquired from the vesting of conditional awards on 16 May 2021 under the EIP Element C.  All Shares were retained.
c)	Price(s) and volume(s)	Price(s): £nil Volume(s): 22,601
d)	Aggregated information -  Volume   -  Price -  Total	22,601 £0.00 £0.00
e)	Date of the transaction	17 May 2021
f)	Place of the transaction	London Stock Exchange (XLON)

Majda Labadi

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Majda Labadi
2	Reason for the notification
a)	Position/status	PDMR
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Hikma Pharmaceuticals PLC
b)	LEI	549300BNS685UXH4JI75
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083
b)	Nature of the transaction	Shares acquired from the vesting of conditional awards on 16 May 2021 under the EIP Element C.  All Shares were retained.
c)	Price(s) and volume(s)	Price(s): £nil Volume(s): 15,855
d)	Aggregated information -  Volume   -  Price -  Total	15,855 £0.00 £0.00
e)	Date of the transaction	17 May 2021
f)	Place of the transaction	London Stock Exchange (XLON)

Bassam Kanaan

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Bassam Kanaan
2	Reason for the notification
a)	Position/status	PDMR
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Hikma Pharmaceuticals PLC
b)	LEI	549300BNS685UXH4JI75
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083
b)	Nature of the transaction	Shares acquired from the vesting of conditional awards on 16 May 2021 under the EIP Element C.  All Shares were retained.
c)	Price(s) and volume(s)	Price(s): £nil Volume(s): 25,729
d)	Aggregated information -  Volume   -  Price -  Total	25,729 £0.00 £0.00
e)	Date of the transaction	17 May 2021
f)	Place of the transaction	London Stock Exchange (XLON)

Khalid Nabilsi

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Khalid Nabilsi
2	Reason for the notification
a)	Position/status	PDMR
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Hikma Pharmaceuticals PLC
b)	LEI	549300BNS685UXH4JI75
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083
b)	Nature of the transaction	Shares acquired from the vesting of conditional awards on 16 May 2021 under the EIP Element C.  All Shares were retained.
c)	Price(s) and volume(s)	Price(s): £nil Volume(s): 23,062
d)	Aggregated information -  Volume   -  Price -  Total	23,062 £0.00 £0.00
e)	Date of the transaction	17 May 2021
f)	Place of the transaction	London Stock Exchange (XLON)

Susan Ringdal

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Susan Ringdal
2	Reason for the notification
a)	Position/status	PDMR
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Hikma Pharmaceuticals PLC
b)	LEI	549300BNS685UXH4JI75
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083
b)	Nature of the transaction	Shares acquired from the vesting of conditional awards on 16 May 2021 under the EIP Element C.  Shares were sold to cover tax and the remainder were retained.
c)	Price(s) and volume(s)	Price(s): £nil Volume(s): 7,522 Price(s): £23.835 Volume(s): 6,735
d)	Aggregated information -  Volume   -  Price -  Total	14,257 £23.835 £160,528.73p
e)	Date of the transaction	17 May 2021
f)	Place of the transaction	London Stock Exchange (XLON)

Hussein Arkhagha

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Hussein Arkhagha
2	Reason for the notification
a)	Position/status	PDMR
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Hikma Pharmaceuticals PLC
b)	LEI	549300BNS685UXH4JI75
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083
b)	Nature of the transaction	Shares acquired from the vesting of conditional awards on 17 May 2021 under the EIP Element B.  All Shares were retained.
c)	Price(s) and volume(s)	Price(s): £nil Volume(s): 11,246
d)	Aggregated information -  Volume   -  Price -  Total	11,246 £0.00 £0.00
e)	Date of the transaction	17 May 2021
f)	Place of the transaction	London Stock Exchange (XLON)

Peter Speirs
Company Secretary, responsible for releasing this announcement
[phone]

17 May 2021

 

END

 

 

DSHBSGDUUUBDGBR